We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use www.guysandstthomasevents.co.uk, remember your settings and improve our services. We also use cookies set by other sites to help us deliver content from their services.
The RBD Symposium explores the diagnosis, treatment, and prognosis of REM Sleep Behavior Disorder, highlighting its link to neurodegeneration. It gathers experts and patient representatives to share research and foster clinical collaboration
Venue:
Governors Hall
Date:
05/12/2025
Location:
St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH
The RBD Symposium comprehensively outlines how to identify and treat patients with RBD, and provides insight on the relevant prognostic implications of this sleep condition. This meeting also offers an invaluable opportunity to learn about the current research landscape on RBD and its links with neurodegeneration.
Involving international and national experts in the field, as well as patient representatives, the RBD Symposium will provide a multi-disciplinary setting for clinicians and healthcare professionals to network and share their knowledge.
Highlights
The intricacies of diagnosing RBD: challenges from a clinical and technical point of view
Prognostic implications of RBD: risk disclosure and progression of the disease
Research advances in the field of RBD and neurodegeneration
Format
This in-person symposium brings international and national experts, and patient advocates, to present lectures, case studies, research updates, round tables, and interactive Q&A sessions.
Who should attend
This one-day symposium is ideal for those working with patients that present with sleep-related complaints and are interested in expanding their knowledge on RBD as a sleep condition with particular long-term implications. This includes, but is not limited to, sleep medicine and neurology consultants, GPs, specialist registrars, clinical psychologists, sleep technologists, clinical nurse specialists, and clinical pharmacists.
